In silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors for Weight Loss from Traditional Chinese Medicine

ASIA unversity > 醫學暨健康學院 > 生物科技學系 > 期刊論文 > Item 310904400/23386

請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/23386

題名:	In silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors for Weight Loss from Traditional Chinese Medicine
作者:	陳語謙;Chen, Calvin Yu-Chian
貢獻者:	生物科技學系
日期:	2012
上傳時間:	2012-12-10 03:39:25 (UTC+0)
摘要:	In silico Identification of Potent Pancreatic Triacylglycerol Lipase Inhibitors for Weight Loss from Traditional Chinese Medicine Pancreatic triacylglycerol lipase (PNLIP) are primary lipases that are critical for triacylglyceride digestion in human. Since reduced metabolism of triacylglyceride might be a plausible concept for weight loss, we screened for potential PNLIP inhibitors from traditional Chinese medicine (TCM) with the aim to identify weight loss candidate compounds. TCM candidates Aurantiamide, Cnidiadin, and 2-hexadecenoic acid exhibited higher Dock Scores than the commercial drug Orlistat, and were also predicted to have inhibitory characteristics against PNLIP using constructed MLR (R(2) = 0.8664) and SVM (R(2) = 0.9030) models. Molecular dynamics indicated that the TCM-PNLIP complexes formed were stable. We identified that the PNLIP binding site has several residues that can serve as anchors, and a hydrophobic corridor that provides additional stability to the complex. Aurantiamide, Cnidiadin, and 2-hexadecenoic acid all have features that correspond to these binding site features, indicating their potential as candidates for PNLIP inhibitors. The information presented in this study may provide helpful insights to designing novel weight-control drugs.
顯示於類別:	[生物科技學系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	347	檢視/開啟

在ASIAIR中所有的資料項目都受到原著作權保護.

資料載入中.....